Seminars in Pediatric Surgery
Volume 15, Issue 3 , Pages 188-198 , August 2006

Pediatric cardiac transplantation

References 

  1. Boucek MM , Edwards LB , Keck BM , et al.   Registry of the International Society for Heart and Lung Transplantation (eighth official pediatric report–2005) . J Heart Lung Transplant . 2005;24:968–982
  2. West LJ , Pollock-Barziv SM , Dipchand AI , et al.   ABO-incompatible heart transplantation in infants . N Engl J Med . 2001;344:793–800
  3. Fullerton DA , Gundry SR , onso de BJ , et al.   The effects of donor-recipient size disparity in infant and pediatric heart transplantation . J Thorac Cardiovasc Surg . 1992;104:1314–1319
  4. Razzouk AJ , Johnston JK , Larsen RL , et al.   Effect of oversizing cardiac allografts on survival in pediatric patients with congenital heart disease . J Heart Lung Transplant . 2005;24:195–199
  5. Scheule AM , Zimmerman GJ , Johnston JK , et al.   Duration of graft cold ischemia does not affect outcomes in pediatric heart transplant recipients . Circulation . 2002;106(12):I163–I167 2002 (suppl 1)
  6. Razzouk AJ , Chinnock RE , Gundry SR , et al.   Transplantation as a primary treatment for hypoplastic left heart syndrome (intermediate-term results) . Ann Thorac Surg . 1996;62:1–7
  7. Bailey LL , Gundry SR , Razzouk AJ , et al.  The Loma Linda University Pediatric Heart Transplant Group   Bless the babies (one hundred fifteen late survivors of heart transplantation during the first year of life) . J Thorac Cardiovasc Surg . 1993;105:805–814
  8. Kawauchi M , Gundry SR , de Begona JA , et al.   Prolonged preservation of human pediatric hearts for transplantation (correlation of ischemic time and subsequent function) . J Heart Lung Transplant . 1993;12:55–58
  9. Mitchell MB , Campbell DN , Clarke DR , et al.   Infant heart transplantation (improved intermediate results) . J Thorac Cardiovasc Surg . 1998;116:242–252
  10. Canter C , Naftel D , Caldwell R , et al.   Survival and risk factors for death after cardiac transplantation in infants. A multi-institutional study. The Pediatric Heart Transplant Study . Circulation . 1997;96:227–231
  11. Fernandez J , Aranda J , Mabbot S , et al.   Overseas procurement of donor hearts (ischemic time effect on postoperative outcomes) . Transplant Proc . 2001;33:3803–3804
  12. Chin C , Miller J , Robbins R , et al.   The use of advanced-age donor hearts adversely affects survival in pediatric heart transplantation . Pediatr Transplant . 1999;3:309–314
  13. Zaroff JG , Rosengard BR , Armstrong WF , et al.   Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations . Circulation . 2002;106:836–841
  14. Shumway NE , Lower RR , Stofer RC . Transplantation of the heart . Adv Surg . 1966;2:265–284
  15. Sievers HH , Weyand M , Kraatz EG , et al.   An alternative technique for orthotopic cardiac transplantation, with preservation of the normal anatomy of the right atrium . Thorac Cardiovasc Surg . 1991;39:70–72
  16. Sarsam MA , Campbell CS , Yonan NA , et al.   An alternative surgical technique in orthotopic cardiac transplantation . J Card Surg . 1993;8:344–349
  17. El Gamel A , Deiraniya AK , Rahman AN , et al.   Orthotopic heart transplantation hemodynamics (does atrial preservation improve cardiac output after transplantation?) . J Heart Lung Transplant . 1996;15:564–571
  18. El Gamel A , Yonan NA , Grant S , et al.   Orthotopic cardiac transplantation (a comparison of standard and bicaval Wythenshawe techniques) . J Thorac Cardiovasc Surg . 1995;109:721–729
  19. Sievers HH , Leyh R , Jahnke A , et al.   Bicaval versus atrial anastomoses in cardiac transplantation. Right atrial dimension and tricuspid valve function at rest and during exercise up to thirty-six months after transplantation . J Thorac Cardiovasc Surg . 1994;108:780–784
  20. Rothman SA , Jeevanandam V , Combs WG , et al.   Eliminating bradyarrhythmias after orthotopic heart transplantation . Circulation . 1996;94(9, suppl):II278–II282
  21. Bleasdale RA , Banner NR , Anyanwu AC , et al.   Determinants of outcome after heterotopic heart transplantation . J Heart Lung Transplant . 2002;21:867–873
  22. Ridley PD , Khaghani A , Musumeci F , et al.   Heterotopic heart transplantation and recipient heart operation in ischemic heart disease . Ann Thorac Surg . 1992;54:333–337
  23. Desruennes M , Muneretto C , Gandjbakhch I , et al.   Heterotopic heart transplantation (current status in 1988) . J Heart Transplant . 1989;8:479–485
  24. Kawaguchi A , Gandjbakhch I , Pavie A , et al.   Factors affecting survival after heterotopic heart transplantation . J Thorac Cardiovasc Surg . 1989;98(5):928–934
  25. Nakatani T , Frazier OH , Lammermeier DE , et al.   Heterotopic heart transplantation (a reliable option for a select group of high-risk patients) . J Heart Transplant . 1989;8:40–47
  26. Michler RE , Sandhu AA . Novel approach for orthotopic heart transplantation in visceroatrial situs inversus . Ann Thorac Surg . 1995;60:194–197
  27. Vricella LA , Razzouk AJ , Gundry SR , et al.   Heart transplantation in infants and children with situs inversus . J Thorac Cardiovasc Surg . 1998;116:82–89
  28. Hershberger RE , Starling RC , Eisen HJ , et al.   Daclizumab to prevent rejection after cardiac transplantation . N Engl J Med . 2005;352:2705–2713
  29. Eisen HJ , Tuzcu EM , Dorent R , et al.   Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients . N Engl J Med . 2003;349:847–858
  30. Keogh A , Richardson M , Ruygrok P , et al.   Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years (a randomized clinical trial) . Circulation . 2004;110:2694–2700
  31. Sindhi R . Sirolimus in pediatric transplant recipients . Transplant Proc . 2003;35(3, suppl):113S–114S
  32. Straatman LP , Coles JG . Pediatric utilization of rapamycin for severe cardiac allograft rejection . Transplant . 2000;70:541–543
  33. Haddad H , MacNeil DM , Howlett J , et al.   Sirolimus, a new potent immunosuppressant agent for refractory cardiac transplantation rejection (two case reports) . Can J Cardiol . 2000;16:221–224
  34. Levy G , Burra P , Cavallari A , et al.   Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2) . Transplant . 2002;73:953–959
  35. Cantarovich M , Elstein E , de Varennes B , et al.   Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients . Transplant . 1999;68:1839–1842
  36. Cantarovich M , Quantz M , Elstein E , et al.   Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction . Transplant Proc . 2000;32:446–448
  37. Morton JM , Aboyoun CL , Malouf MA , et al.   Enhanced clinical utility of de novo cyclosporine C2 monitoring after lung transplantation . J Heart Lung Transplant . 2004;23:1035–1039
  38. Bhargava H , Donner RM , Sanchez G , et al.   Endomyocardial biopsy after heart transplantation in children . J Heart Transplant . 1987;6:298–302
  39. Chin C , Akhtar MJ , Rosenthal DN , et al.   Safety and utility of the routine surveillance biopsy in pediatric patients 2 years after heart transplantation . J Pediatr . 2000;136:238–242
  40. Chin C , Naftel DC , Singh TP , et al.   Risk factors for recurrent rejection in pediatric heart transplantation (a multicenter experience) . J Heart Lung Transplant . 2004;23:178–185
  41. Caves PK , Stinson EB , Billingham ME , et al.   Diagnosis of human cardiac allograft rejection by serial cardiac biopsy . J Thorac Cardiovasc Surg . 1973;66:461–466
  42. Caves PK , Stinson EB , Billingham ME , et al.   Serial transvenous biopsy of the transplanted human heart. Improved management of acute rejection episodes . Lancet . 1974;1:821–826
  43. Billingham ME . Some recent advances in cardiac pathology . Hum Pathol . 1979;10:367–386
  44. Mehra MR , Kobashigawa JA . Advances in heart and lung transplantation 2004 (Report from the 24th International Society for Heart and Lung Transplantation Annual Meeting, San Francisco, April 21-24, 2004) . J Heart Lung Transplant . 2004;23:925–930
  45. Deng MC , Mehra MR , Eisen HJ . Cardiac allograft monitoring using a novel clinical algorithm based on peripheral leukocyte gene expression profiling . Circulation . 2003;108(suppl):1801
  46. Mehra MR , Kobashigawa J , Hunt S , et al.   Molecular testing and prediction of clinical outcome in heart transplantation (a prospective multicenter trial) . J Heart Lung Transplant . 2004;23(suppl):S106
  47. Ross M , Kouretas P , Gamberg P , et al.   10 and 20-Year survivors of pediatric orthotopic heart transplantation . J Heart Lung Transplant . 2006;25:261–270
  48. Chrisant MR , Naftel DC , Drummond-Webb J , et al.   Fate of infants with hypoplastic left heart syndrome listed for cardiac transplantation (a multicenter study) . J Heart Lung Transplant . 2005;24:576–582
  49. Bernstein D , Naftel D , Chin C , Addonizio L , Gamberg P , Hus D , et al.   Outcome of listing for cardiac transplantation for failed Fontan (A follow-up multi-institutional study) . J Heart Lung Transplant . 2004;23:S162
  50. Schowengerdt KO , Naftel DC , Seib PM , et al.  The Pediatric Heart Transplant Study Group   Infection after pediatric heart transplantation (results of a multiinstitutional study) . J Heart Lung Transplant . 1997;16:1207–1216
  51. Pahl E , Fricker FJ , Trento A , et al.   Late follow-up of children after heart transplantation . Transplant Proc . 1988;20(1, suppl 1):743–746
  52. Schroeder JS , Gao SZ , Alderman EL , et al.   A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients . N Engl J Med . 1993;328:164–170
  53. Schroeder JS , Gao SZ . Calcium blockers and atherosclerosis (lessons from the Stanford Transplant Coronary Artery Disease/Diltiazem Trial) . Can J Cardiol . 1995;11:710–715
  54. English J , Evan A , Houghton DC , et al.   Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function . Transplantation . 1987;44:135–141
  55. Mihatsch MJ , Thiel G , Ryffel B . Histopathology of cyclosporine nephrotoxicity . Transplantat Proc . 1988;20(3, suppl 3):759–771
  56. Mihatsch MJ , Thiel G , Ryffel B . Morphologic diagnosis of cyclosporine nephrotoxicity . Semin Diagn Pathol . 1988;5:104–121
  57. Chinnock R , Baum M , Chinnock R , et al.   Somatic growth in infant heart transplant recipients . Pediatr Transplant . 1998;2:30–34
  58. Hirsch R , Huddleston CB , Mendeloff EN , et al.   Infant and donor organ growth after heart transplantation in neonates with hypoplastic left heart syndrome . J Heart Lung Transplant . 1996;15:1093–1100
  59. Bernstein D , Kolla S , Miner M , et al.   Cardiac growth after pediatric heart transplantation . Circulation . 1992;85:1433–1439
  60. Zales VR , Wright KL , Pahl E , et al.   Normal left ventricular muscle mass and mass/volume ratio after pediatric cardiac transplantation . Circulation . 1994;90(5):II61–II65
  61. Glendenning P , Kent GN , Adler BD , et al.   High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry . Clin Endocrinol . 1999;50:347–355
  62. Shane E , Rivas M , McMahon DJ , et al.   Bone loss and turnover after cardiac transplantation . J Clin Endocrinol Metab . 1997;82:1497–1506
  63. Sambrook PN , Kelly PJ , Keogh AM , et al.   Bone loss after heart transplantation (a prospective study) . J Heart Lung Transplant . 1994;13(1):116–120
  64. Cohen A , Addonizio LJ , Lamour JM , et al.   Osteoporosis in adult survivors of adolescent cardiac transplantation may be related to hyperparathyroidism, mild renal insufficiency, and increased bone turnover . J Heart Lung Transplant . 2005;24:696–702
  65. Ho M , Jaffe R , Miller G , et al.   The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children . Transplant . 1988;45:719–727
  66. Chadburn A , Cesarman E , Knowles DM . Molecular pathology of posttransplantation lymphoproliferative disorders . Semin Diagn Pathol . 1997;14:15–26
  67. Zangwill SD , Hsu DT , Kichuk MR , et al.   Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients . J Heart Lung Transplant . 1998;17:1161–1166
  68. Bernstein D , Baum D , Berry G , et al.   Neoplastic disorders after pediatric heart transplantation . Circulation . 1993;88(5):II230–II237
  69. Costanzo MR , Naftel DC , Pritzker MR , et al.   Heart transplant coronary artery disease detected by coronary angiography (a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database) . J Heart Lung Transplant . 1998;17:744–753
  70. Taylor DO , Edwards LB , Boucek MM , Trulock EP , Keck BM , Hertz MI . The Registry of the International Society for Heart and Lung Transplantation (twenty-first official adult heart transplant report–2004) . J Heart Lung Transplant . 2004;23:796–803
  71. Valantine H , Rickenbacker P , Kemna M , et al.   Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease (a prospective study) . Circulation . 2001;103:2144–2152
  72. Costanzo-Nordin MR . Cardiac allograft vasculopathy (relationship with acute cellular rejection and histocompatibility) . J Heart Lung Transplant . 1992;11(3):S90–S103
  73. Grattan MT , Moreno-Cabral CE , Starnes VA , et al.   Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis . JAMA . 1989;261:3561–3566
  74. Kobashigawa JA , Miller L , Yeung A , et al.  Sandoz/CVIS Investigators   Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound . J Heart Lung Transplant . 1995;14(6):S221–S226
  75. Valantine H . Cardiac allograft vasculopathy after heart transplantation (risk factors and management) . J Heart Lung Transplant . 2004;23(5, suppl):S187–S193
  76. Tham EBC , Yeung AC , Cheng CWB , et al.   Experience of percutaneous coronary intervention in the management of pediatric cardiac allograft vasculopathy . J Heart Lung Transplant . 2005;24:769–773
  77. Radovancevic B , McGiffin DC , Kobashigawa JA , et al.   Retransplantation in 7,290 primary transplant patients (a 10-year multi-institutional study) . J Heart Lung Transplant . 2003;22:862–868
  78. Kanter KR , Vincent RN , Berg AM , et al.   Cardiac retransplantation in children . Ann Thorac Surg . 2004;78:644–649
  79. Dearani JA , Razzouk AJ , Gundry SR , et al.   Pediatric cardiac retransplantation (intermediate-term results) . Ann Thorac Surg . 2001;71:66–70
  80. Razzouk AJ , Chinnock RE , Dearani JA , et al.   Cardiac retransplantation for graft vasculopathy in children (should we continue to do it?) . Arch Surg . 1998;133:881–885
  81. Chin C , Rosenthal D , Bernstein D . Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients . Pediatr Transplant . 2000;4:193–199
  82. Seipelt IM , Crawford SE , Rodgers S , et al.   Hypercholesterolemia is common after pediatric heart transplantation (initial experience with pravastatin) . J Heart Lung Transplant . 2004;23:317–322
  83. Chin C , Gamberg P , Miller J , et al.   Efficacy and safety of atorvastatin after pediatric heart transplantation . J Heart Lung Transplant . 2002;21:1213–1217
  84. Cutts JL , Bankhurst AD . Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2 . J Cell Physiol . 1990;145:244–252
  85. Cutts JL , Scallen TJ , Watson J , et al.   Role of mevalonic acid in the regulation of natural killer cell cytotoxicity . J Cell Physiol . 1989;139:550–557
  86. Kobashigawa JA , Katznelson S , Laks H , et al.   Effect of pravastatin on outcomes after cardiac transplantation . N Engl J Med . 1995;333:621–627
  87. Meiser BM , Billingham ME , Morris RE . Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease . Lancet . 1991;338:1297–1298
  88. Mancini D , Pinney S , Burkhoff D , et al.   Use of rapamycin slows progression of cardiac transplantation vasculopathy . Circulation . 2003;108:48–53
  89. Ruygrok PN , Webber B , Faddy S , et al.   Angiographic regression of cardiac allograft vasculopathy after introducing sirolimus immunosuppression . J Heart Lung Transplant . 2003;22:1276–1279
  90. Wray J , Radley-Smith R . Depression in pediatric patients before and 1 year after heart or heart-lung transplantation . J Heart Lung Transplant . 2004;23:1103–1110
  91. Wray J , Long T , Radley-Smith R , et al.   Returning to school after heart or heart-lung transplantation (how well do children adjust?) . Transplantation . 2001;72:100–106
  92. Fiser WP , Yetman AT , Gunselman RJ , et al.   Pediatric arteriovenous extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation . J Heart Lung Transplant . 2003;22:770–777
  93. Helman DN , Addonizio LJ , Morales DL , et al.   Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant . J Heart Lung Transplant . 2000;19:121–126
  94. Ashton RC , Oz MC , Michler RE , et al.   Left ventricular assist device options in pediatric patients . ASAIO J . 1995;41:M277–M280
  95. McBride LR , Naunheim KS , Fiore AC , et al.   Clinical experience with 111 Thoratec ventricular assist devices . Ann Thorac Surg . 1999;67:1233–1238
  96. Korfer R , El-Banayosy A , Arusoglu L , et al.   Single-center experience with the Thoratec ventricular assist device . J Thorac Cardiovasc Surg . 2000;119:596–600
  97. Reinhartz O , Keith FM , El-Banayosy A , et al.   Multicenter experience with the Thoratec ventricular assist device in children and adolescents . J Heart Lung Transplant . 2001;20:439–448
  98. Reinhartz O , Copeland JG , Farrar DJ . Thoratec ventricular assist devices in children with less than 1.3 m2 of body surface area . ASAIO J . 2003;49:727–730
  99. Hetzer R , Loebe M , Potapov EV , et al.   Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children . Ann Thorac Surg . 1998;66:1498–1506
  100. Esmore DS , Spratt PM , Keogh AM , et al.   Cyclosporine and azathioprine immunosuppression without maintenance steroids (a prospective randomized trial) . J Heart Transplant . 1989;8:194–199
  101. Lee KF , Pierce JD , Hess ML , et al.   Cardiac transplantation with corticosteroid-free immunosuppression (long-term results) . Ann Thorac Surg . 1991;52:211–217
  102. Renlund DG , O’Connell JB , Gilbert EM , et al.   Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation . J Heart Lung Transplant . 1987;6:71–78
  103. Canter CE , Moorhead S , Saffitz JE , et al.   Steroid withdrawal in the pediatric heart transplant recipient initially treated with triple immunosuppression . J Heart Lung Transplant . 1994;13:74–79
  104. Kobashigawa JA , Stevenson LW , Brownfield ED , et al.   Initial success of steroid weaning late after heart transplantation . J Heart Lung Transplant . 1992;11:428–430
  105. Miller LW , Wolford T , McBride LR , et al.   Successful withdrawal of corticosteroids in heart transplantation . J Heart Lung Transplant . 1992;11:431–434
  106. Oaks TE , Wannenberg T , Close SA , et al.   Steroid-free maintenance immunosuppression after heart transplantation . Ann Thorac Surg . 2001;72:102–106
  107. Felkel TO , Smith AL , Reichenspurner HC , et al.   Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy . J Heart Lung Transplant . 2002;21:530–539
  108. Mehra MR , Ventura HO , Smart FW , et al.   An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy . Am J Cardiol . 1995;75:853–854
  109. Taylor DO , Ensley RD , Olsen SL , et al.   Mycophenolate mofetil (RS-61443) (preclinical, clinical, and three-year experience in heart transplantation) . J Heart Lung Transplant . 1994;13:571–582
  110. Robbins RC , Barlow CW , Oyer PE , et al.   Thirty years of cardiac transplantation at Stanford university . J Thorac Cardiovasc Surg . 1999;117:939–951
  111. Redonnet M , Tron C , Koning R , et al.   Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation . Transplant Proc . 2000;32:463–465
  112. Halle AA , Wilson RF , Massin EK , et al.   Coronary angioplasty in cardiac transplant patients. Results of a multicenter study . Circulation . 1992;86:458–462
  113. Halle AA , DiSciascio G , Massin EK , et al.   Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients . J Am Coll Cardiol . 1995;26:120–128

PII: S1055-8586(06)00042-4

doi: 10.1053/j.sempedsurg.2006.03.011

Seminars in Pediatric Surgery
Volume 15, Issue 3 , Pages 188-198 , August 2006

Article Tools

* Image Usage & Resolution